AAV-MICRODYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY: ENHANCEMENT OF IMMUNE PROTECTION BY CAPSID BIOENGINEERING
$345,664FY2024Defense Health AgencyDOD
The Royal Veterinary College
Investigators
View source on USAspending →AAV-MICRODYSTROPHIN GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY: ENHANCEMENT OF IMMUNE PROTECTION BY CAPSID BIOENGINEERING · GrantIndex